We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Recombinant angiotensin II therapy in a child with cardiac dysfunction and Pandoraea and Candida sepsis.
- Authors
Kim, Michael E.; Goldstein, Stuart L.; Chlebowski, Meghan M.
- Abstract
Recombinant angiotensin II is an emerging drug therapy for refractory hypotension. Its use is relevant to patients with disruption of the renin–angiotensin–aldosterone system denoted by elevated direct renin levels. We present a child that responded to recombinant angiotensin II in the setting of right ventricular hypertension and multi-organism septic shock.
- Publication
Cardiology in the Young, 2023, Vol 33, Issue 11, p2393
- ISSN
1047-9511
- Publication type
Article
- DOI
10.1017/S1047951123001221